Gonzalez, Raul S <br/><br/>
Cyclin-dependent kinase inhibitor 2A (p16) distinguishes well-differentiated liposarcoma from lipoma.  [electronic resource] 

 -  Histopathology  Jun 2013 
 - 1109-11 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1365-2559 
<br/><br/><label>Standard No.: </label>10.1111/his.12112  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers, Tumor--metabolism<br/>Cyclin-Dependent Kinase Inhibitor p16--metabolism<br/>Diagnosis, Differential<br/>Female<br/>Humans<br/>Lipoma--diagnosis<br/>Liposarcoma--diagnosis<br/>Male<br/>Middle Aged<br/>Soft Tissue Neoplasms--diagnosis